JP2023504286A5 - - Google Patents
Info
- Publication number
- JP2023504286A5 JP2023504286A5 JP2022534289A JP2022534289A JP2023504286A5 JP 2023504286 A5 JP2023504286 A5 JP 2023504286A5 JP 2022534289 A JP2022534289 A JP 2022534289A JP 2022534289 A JP2022534289 A JP 2022534289A JP 2023504286 A5 JP2023504286 A5 JP 2023504286A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- composition according
- immunomodulator
- dendrimer
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943705P | 2019-12-04 | 2019-12-04 | |
| US62/943,705 | 2019-12-04 | ||
| US202063108186P | 2020-10-30 | 2020-10-30 | |
| US63/108,186 | 2020-10-30 | ||
| PCT/US2020/063332 WO2021113651A2 (en) | 2019-12-04 | 2020-12-04 | Dendrimer compositions and methods for drug delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504286A JP2023504286A (ja) | 2023-02-02 |
| JP2023504286A5 true JP2023504286A5 (enExample) | 2023-12-13 |
Family
ID=74104190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534289A Pending JP2023504286A (ja) | 2019-12-04 | 2020-12-04 | 薬物送達のためのデンドリマー組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20230226199A1 (enExample) |
| EP (1) | EP4069307A2 (enExample) |
| JP (1) | JP2023504286A (enExample) |
| CN (1) | CN115103689A (enExample) |
| AU (1) | AU2020397063A1 (enExample) |
| CA (1) | CA3163886A1 (enExample) |
| IL (1) | IL293604A (enExample) |
| PH (1) | PH12022551368A1 (enExample) |
| WO (1) | WO2021113651A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021113662A2 (en) | 2019-12-04 | 2021-06-10 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
| JP2023522984A (ja) | 2020-04-24 | 2023-06-01 | アシュバッタ セラピューティクス， インコーポレイテッド | 重症急性呼吸促迫症候群の処置のためのデンドリマー組成物および方法 |
| PH12023550133A1 (en) * | 2020-07-17 | 2024-06-24 | Ashvattha Therapeutics Inc | Dendrimer compositions and methods for drug delivery to injured kidney |
| JP2023549081A (ja) * | 2020-10-30 | 2023-11-22 | アシュバッタ セラピューティクス， インコーポレイテッド | Ｐｅｔイメージングおよび放射線療法のための放射標識エーテルデンドリマーコンジュゲート |
| WO2022192135A1 (en) * | 2021-03-08 | 2022-09-15 | Transdermal Biotechnology, Inc. | Dendrimer-n-actyl-l-cysteine conjugates for treatment or prevention of aging skin or other indications |
| TW202313118A (zh) * | 2021-06-10 | 2023-04-01 | 美商阿什瓦塔治療股份有限公司 | 樹枝狀體結合物及其使用方法 |
| EP4490158A4 (en) * | 2022-03-10 | 2026-01-07 | Curators Of The University Of Missouri The | NEW PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITOR, COMPOSITIONS CONTAINING IT, METHODS OF MANUFACTURING IT AND METHODS OF TREATING A DISEASE |
| WO2023183367A1 (en) * | 2022-03-22 | 2023-09-28 | Board Of Regents Of The University Of Nebraska | Metformin nanoformulations and methods of use thereof |
| EP4496568A1 (en) * | 2022-03-22 | 2025-01-29 | Board of Regents of the University of Nebraska | Metformin nanoformulations and methods of use thereof |
| CN114796492B (zh) * | 2022-05-12 | 2023-01-13 | 大连理工大学 | 一种超声驱动纳米声敏疫苗及其制备和应用 |
| CN116196292B (zh) * | 2023-02-16 | 2024-08-16 | 东华大学 | 一种靶向肽修饰的聚酰胺-胺树状大分子复合纳米材料及其制备方法 |
| WO2025183982A1 (en) * | 2024-02-28 | 2025-09-04 | Washington State University | Psma-targeted dendrimer nanoplatform for cancer detection and therapy |
| WO2025226820A1 (en) * | 2024-04-23 | 2025-10-30 | Ashvattha Therapeutics, Inc. | Csf1r inhibitor dendrimer conjugates and uses thereof |
| CN118108799B (zh) * | 2024-04-29 | 2024-07-12 | 内蒙古工业大学 | 基于DMXAA的含Se多肽药物及其制备方法和应用 |
| WO2025259214A1 (en) | 2024-06-14 | 2025-12-18 | EGE Kimya San. ve Tic. A.S. | Use of dendrimer compounds as anti-skinning agents |
| WO2025259215A1 (en) | 2024-06-14 | 2025-12-18 | EGE Kimya San. ve Tic. A.S. | Use of dendrimer compounds as complexing ligands for metal activity enhancement |
| CN118846078A (zh) * | 2024-07-02 | 2024-10-29 | 中国人民解放军空军军医大学 | Ndrg2基因联合分子靶向抑制剂在制备肾细胞癌治疗药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856807A (en) | 1972-03-13 | 1974-12-24 | Upjohn Co | L-({60 s,5s)-{60 -amino-3-chloro-2-isoxazoline-5-acetic acid |
| US3878047A (en) | 1973-02-02 | 1975-04-15 | Upjohn Co | Process for production of AT-125 |
| US5087639A (en) | 1988-11-02 | 1992-02-11 | The Upjohn Company | Preventing CNS toxicity of acivicin when used with four large neutral amino acids |
| CA2786794C (en) * | 2004-03-23 | 2017-09-12 | Complex Biosystems Gmbh | Aromatic polymeric cascade prodrug linker reagent |
| EP2214646B1 (en) | 2007-10-05 | 2021-06-23 | Wayne State University | Dendrimers for sustained release of compounds |
| CA2767163A1 (en) | 2009-06-15 | 2010-12-23 | Wayne State University | Dendrimer based nanodevices for therapeutic and imaging purposes |
| WO2011123591A1 (en) | 2010-03-31 | 2011-10-06 | Wayne State University | Injectable dendrimer hydrogel nanoparticles |
| US9198973B2 (en) * | 2013-06-17 | 2015-12-01 | Fundacion Fraunhofer Chile Research | PAMAM, spacer molecule and cafestol polymers |
| EP3137116B1 (en) * | 2014-04-30 | 2020-12-16 | The Johns Hopkins University | Dendrimer compositions and their use in treatment of diseases of the eye |
| ES2910550T3 (es) * | 2014-05-21 | 2022-05-12 | Icd Therapeutics Gmbh | Conjugados terapéuticos con dendrímeros sulfatados para selección de objetivos intracelulares |
| EP3180031A1 (en) * | 2014-08-13 | 2017-06-21 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| WO2016025745A1 (en) | 2014-08-13 | 2016-02-18 | The Johns Hopkins University | Dendrimer compositions and use in treatment of neurological and cns disorders |
| MX2017007873A (es) * | 2014-12-15 | 2017-11-06 | Univ Johns Hopkins | Formulaciones de sunitinib y metodos para uso de las mismas en el tratamiento de trastornos oculares. |
| KR101918346B1 (ko) * | 2015-05-06 | 2018-11-13 | 경북대학교 산학협력단 | 난용성 활성물질의 수용성 덴드리머 복합체 |
| CN108289872B (zh) * | 2015-10-29 | 2021-04-02 | 约翰霍普金斯大学 | 树枝状聚合物组合物和其在坏死性小肠结肠炎和其它胃肠道病症治疗中的用途 |
| US20190142953A1 (en) * | 2016-05-10 | 2019-05-16 | Massachusetts Institute Of Technology | Dendrimer-Drug Conjugates, Hydrogel Compositions, and Methods |
| TWI773730B (zh) * | 2017-02-22 | 2022-08-11 | 瑞典商阿斯特捷利康公司 | 治療性樹枝狀聚合物 |
| US12290571B2 (en) * | 2017-10-05 | 2025-05-06 | Sony Group Corporation | Programmable dendritic drugs |
| WO2019094952A1 (en) * | 2017-11-10 | 2019-05-16 | The Johns Hopkins University | Dendrimer delivery system and methods of use thereof |
| WO2020132196A1 (en) * | 2018-12-21 | 2020-06-25 | Tiba Biotech Llc | Nanoparticle compositions for efficient nucleic acid delivery and methods of making and using the same |
| WO2021113662A2 (en) * | 2019-12-04 | 2021-06-10 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
-
2020
- 2020-12-04 CA CA3163886A patent/CA3163886A1/en active Pending
- 2020-12-04 US US17/782,592 patent/US20230226199A1/en active Pending
- 2020-12-04 EP EP20830427.9A patent/EP4069307A2/en active Pending
- 2020-12-04 US US17/112,541 patent/US20210170040A1/en not_active Abandoned
- 2020-12-04 IL IL293604A patent/IL293604A/en unknown
- 2020-12-04 PH PH1/2022/551368A patent/PH12022551368A1/en unknown
- 2020-12-04 WO PCT/US2020/063332 patent/WO2021113651A2/en not_active Ceased
- 2020-12-04 JP JP2022534289A patent/JP2023504286A/ja active Pending
- 2020-12-04 AU AU2020397063A patent/AU2020397063A1/en active Pending
- 2020-12-04 CN CN202080095453.0A patent/CN115103689A/zh active Pending
-
2022
- 2022-10-07 US US17/962,297 patent/US20230372499A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6823067B2 (ja) | 生体直交型組成物 | |
| EP3606559B1 (en) | Bioorthogonal compositions | |
| JP2023135666A (ja) | Ｐｓｍａリガンドコンジュゲートによる併用療法 | |
| IL322637A (en) | Amanita toxin bracelet with branched connectors | |
| WO2016057554A1 (en) | Carrier-antibody compositions and methods of making and using the same | |
| JP7854224B2 (ja) | 抗がん活性を有するａｄｐ－リボース結合ペプチドおよびその用途 | |
| US20240009321A1 (en) | Immunogenic nanovesicles for cancer immunotherapy | |
| US20260076991A1 (en) | Hyaluronic Acid Nanoparticles Comprising NADPH Oxidases Inhibitors and Uses in Treating Cancer | |
| KR102929813B1 (ko) | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 | |
| CN110062633A (zh) | 酪氨酸衍生物以及包含所述酪氨酸衍生物的组合物 | |
| JP2019523783A (ja) | がんの治療に有用なポルフィリン化合物及び組成物 | |
| US20090281105A1 (en) | Radiotherapy enhancer | |
| JP2011225471A (ja) | 抗癌剤の効果増強剤 | |
| JP2020516612A (ja) | 癌の治療のための化合物、組成物およびその使用 | |
| KR102346268B1 (ko) | 경구 항암 전구약물을 포함하는 복합체, 이의 제조방법 및 이의 용도 | |
| EP4509133A1 (en) | Adp-ribose-binding peptide for preventing or treating cancer, and combination therapy of adp-ribose | |
| US20250255829A1 (en) | Multifunctional Nanoparticles and Uses in Managing Cancer and Cardiovascular Diseases | |
| JP2021521174A (ja) | 癌治療のためのエーテル型リン脂質類似体の分割投与 | |
| CA3255803A1 (en) | Combination therapy with adp-ribose binding peptide and adp-ribose for prevention or treatment of cancer | |
| TW202506190A (zh) | 利用抗ｍｕｃ１抗體－藥物結合物投予的藥劑低敏感性癌之治療方法 | |
| WO2020076756A1 (en) | Bone-targeting therapeutic compositions and methods of using them | |
| OA18218A (en) | Carrier-antibody compositions and methods of making and using the same | |
| MX2007012171A (es) | Mejorador de radioterapia. | |
| HK1240924A1 (en) | A deuterated triazolopyridazine as a kinase modulator |